In vivo and in vitro experiments also proved that Notoginsenoside R1 could activate Akt and enhance the expression of BDNF, including the transcriptional level of its upstream target gene CREB, so as to achieve the recovery of neurological function after stroke [153]. The gene discussed is AKT1; the disease is stroke disorder.